Drug Trials Snapshot - EBANGA

A new DRUG TRIALS SNAPSHOT is now available. EBANGA is a drug used to treat children and adults who have an infection caused by Zaire ebolavirus. Zaire ebolavirus infection (sometimes called Ebola or Ebola virus disease) is a rare, contagious, rapidly progressive and often deadly disease. EBANGA is an injection. It is given one time by a healthcare provider directly into the vein (intravenous infusion) over 60 minutes. The amount of the drug to be administered is based on the patient's weight.   See more Drug Trials Snapshots or contact us with questions at Snapshots@fda.hhs.gov     Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA